Genetic variants of CYP2R1 are key regulators of serum vitamin D levels and incidence of myocardial infarction in middle-aged Egyptians
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Sedky N.K. | |
dc.contributor.author | Rahman M.F.A. | |
dc.contributor.author | Hassanein S.I. | |
dc.contributor.author | Gad M.Z. | |
dc.contributor.other | Clinical Biochemistry Unit | |
dc.contributor.other | Biochemistry Department | |
dc.contributor.other | Faculty of Pharmacy and Biotechnology | |
dc.contributor.other | German University in Cairo | |
dc.contributor.other | New Cairo City | |
dc.contributor.other | 11835 | |
dc.contributor.other | Egypt; Zewail City of Science and Technology | |
dc.contributor.other | Giza | |
dc.contributor.other | 12566 | |
dc.contributor.other | Egypt; Biochemistry Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | October University for Modern Science and Arts (MSA) | |
dc.contributor.other | 6th of October City | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:41:05Z | |
dc.date.available | 2020-01-09T20:41:05Z | |
dc.date.issued | 2018 | |
dc.description | Scopus | |
dc.description.abstract | Background: Myocardial Infarction (MI) is one of the leading causes of morbidity and mortality in Egypt and worldwide. Vitamin D deficiency has long been linked to incidence of cardiovascular diseases. Several factors were reported to contribute to serum vitamin D level including exposure to sunlight. However, genetic variations in the vitamin D metabolic pathways have also been considered as strong determinants of vitamin D levels. CYP2R1 is the major 25-hydroxylase enzyme that is responsible for the 1st activation step of vitamin D. Objective: to investigate the contribution of polymorphisms in CYP2R1 gene to vitamin D deficiency and incidence of MI in Egyptians. Methods: The study included 323 subjects; 185 MI patients and 138 healthy controls. Serum 25OHD3, 25OHD2 and total 25OHD levels were measured using LC-MS/MS. SNPs rs2060793 and rs1993116 were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) which is considered one of the most commonly used techniques in genotyping. SNP rs10766197 was detected using TaqMan allele discrimination assay. Results: Serum 25OHD3, 25OHD2 and total 25OHD levels were found to be significantly lower in MI patients than controls. The three studied SNPs were associated with significantly different total 25OHD levels and their genotype distributions differed significantly between MI patients and controls where the high risk genotypes were AG/AA for rs2060793, AG/GG for rs1993116 and AG/AA for rs10766197. Additionally, the concurrent presence of high risk genotypes of the three studied SNPs rendered those individuals at extremely higher risk for MI than each individual SNP (OR 14.1, 95% CI (3.1-64.7), p-value = < 0.0001). Conclusions: Genetic variants of CYP2R1 are key determinants of serum 25OHD levels and are highly associated with MI risk. � 2018 Bentham Science Publishers. | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=15581&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/10.2174/1389201019666180528082737 | |
dc.identifier.doi | PubMed ID 29804528 | |
dc.identifier.issn | 13892010 | |
dc.identifier.other | https://doi.org/10.2174/1389201019666180528082737 | |
dc.identifier.other | PubMed ID 29804528 | |
dc.identifier.uri | https://t.ly/q2RkJ | |
dc.language.iso | English | en_US |
dc.publisher | Bentham Science Publishers B.V. | en_US |
dc.relation.ispartofseries | Current Pharmaceutical Biotechnology | |
dc.relation.ispartofseries | 19 | |
dc.subject | 25-hydroxyvitamin D | en_US |
dc.subject | CYP2R1 | en_US |
dc.subject | Egyptians | en_US |
dc.subject | Myocardial infarction | en_US |
dc.subject | Polymorphisms | en_US |
dc.subject | Vitamin D | en_US |
dc.subject | 25 hydroxyvitamin D | en_US |
dc.subject | colecalciferol | en_US |
dc.subject | genomic DNA | en_US |
dc.subject | vitamin D | en_US |
dc.subject | vitamin D receptor | en_US |
dc.subject | cholestanetriol 26 monooxygenase | en_US |
dc.subject | CYP2R1 protein, human | en_US |
dc.subject | cytochrome P450 family 2 | en_US |
dc.subject | vitamin D | en_US |
dc.subject | 5' flanking region | en_US |
dc.subject | adult | en_US |
dc.subject | Article | en_US |
dc.subject | cardiovascular risk | en_US |
dc.subject | controlled study | en_US |
dc.subject | CYP2R1 gene | en_US |
dc.subject | DNA extraction | en_US |
dc.subject | Egyptian | en_US |
dc.subject | enzyme linked immunosorbent assay | en_US |
dc.subject | female | en_US |
dc.subject | gene | en_US |
dc.subject | gene frequency | en_US |
dc.subject | genetic variability | en_US |
dc.subject | genotype | en_US |
dc.subject | heart infarction | en_US |
dc.subject | heterozygosity | en_US |
dc.subject | high risk population | en_US |
dc.subject | homozygosity | en_US |
dc.subject | human | en_US |
dc.subject | intron | en_US |
dc.subject | liquid chromatography-mass spectrometry | en_US |
dc.subject | low risk population | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | middle aged | en_US |
dc.subject | promoter region | en_US |
dc.subject | restriction fragment length polymorphism | en_US |
dc.subject | single nucleotide polymorphism | en_US |
dc.subject | vitamin blood level | en_US |
dc.subject | blood | en_US |
dc.subject | Egypt | en_US |
dc.subject | genetics | en_US |
dc.subject | heart infarction | en_US |
dc.subject | incidence | en_US |
dc.subject | risk | en_US |
dc.subject | vitamin D deficiency | en_US |
dc.subject | Cholestanetriol 26-Monooxygenase | en_US |
dc.subject | Cytochrome P450 Family 2 | en_US |
dc.subject | Egypt | en_US |
dc.subject | Female | en_US |
dc.subject | Genotype | en_US |
dc.subject | Humans | en_US |
dc.subject | Incidence | en_US |
dc.subject | Male | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Myocardial Infarction | en_US |
dc.subject | Polymorphism, Single Nucleotide | en_US |
dc.subject | Risk | en_US |
dc.subject | Vitamin D | en_US |
dc.subject | Vitamin D Deficiency | en_US |
dc.title | Genetic variants of CYP2R1 are key regulators of serum vitamin D levels and incidence of myocardial infarction in middle-aged Egyptians | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Muscogiuri, G., Altieri, B., Annweiler, C., Balercia, G., Pal, H., Boucher, B.J., Cannell, J.J., Kotsa, K., Vitamin D and chronic diseases: The current state of the art (2017) Archiv. Toxicol., 91 (1), pp. 97-107; Wang, T.J., Vitamin D and cardiovascular disease (2016) Ann. Rev. Med., 67, pp. 261-272; Liu, W.-C., Wu, C.-C., Hung, Y.-M., Liao, M.-T., Shyu, J.-F., Lin, Y.-F., Lu, K.-C., Yeh, K.-C., Pleiotropic effects of vitamin D in chronic kidney disease (2016) Clin. Chim. Acta, 453, pp. 1-12; Correia, L.C., Sodr�, F., Garcia, G., Sabino, M., Brito, M., Kalil, F., Barreto, B., Noya-Rabelo, M.M., Relation of severe deficiency of vitamin D to cardiovascular mortality during acute coronary syndromes (2013) Amer. J. Cardiol., 111 (3), pp. 324-327; Gotsman, I., Shauer, A., Zwas, D.R., Hellman, Y., Keren, A., Lotan, C., Admon, D., Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome (2012) Europ. J. Heart Fail., 14 (4), pp. 357-366; Holick, M.F., Vitamin D deficiency (2007) N. Engl. J. Med., 2007 (357), pp. 266-281; Shinkyo, R., Sakaki, T., Kamakura, M., Ohta, M., Inouye, K., Metabolism of vitamin D by human microsomal CYP2R1 (2004) Biochemic. Biophysic. Res. Commun., 324 (1), pp. 451-457; Jolliffe, D.A., Walton, R.T., Griffiths, C.J., Martineau, A.R., Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies (2016) J. Steroid Biochem. Mol. Biol., 164, pp. 18-29; Brouwer-Brolsma, E.M., Vaes, A.M., van der Zwaluw, N.L., van Wijngaarden, J.P., Swart, K.M., Ham, A.C., van Dijk, S.C., van Schoor, N.M., Relative importance of summer sun exposure, vitamin D intake, and genes to vitamin D status in Dutch older adults: The B-PROOF study (2016) J. Steroid Biochem. Mol. Biol., 164, pp. 168-176; Ye, Z., Sharp, S.J., Burgess, S., Scott, R.A., Imamura, F., Langenberg, C., Wareham, N.J., Forouhi, N.G., Consortium, I., Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: A mendelian randomisation study (2015) Lancet Diabet. Endocrinol., 3 (1), pp. 35-42; Simon, K.C., Munger, K., Kraft, P., Hunter, D., de Jager, P., Ascherio, A., Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis (2011) J. Neurol., 258 (9), pp. 1676-1682; Zittermann, A., Schleithoff, S.S., Koerfer, R., Putting cardiovascular disease and vitamin D insufficiency into perspective (2005) Brit. J. Nutrit., 94 (4), pp. 483-492; Lund, B., Badskjaer, J., Lund, B., Soerensen, O., Vitamin D and ischaemic heart disease (1978) Hormone Metabolic Res, 10 (6), pp. 553-556; Scragg, R., Jackson, R., Holdaway, I.M., Lim, T., Beaglehole, R., Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: A community-based study (1990) Int. J. Epi-Demiol., 19 (3), pp. 559-563; Kolaszko, A., Nowalany-Kozielska, E., Ceranowicz, P., Morawiec, B., Kubiak, G., The role of parathyroid hormone and vitamin d serum concentrations in patients with cardiovascular diseases (2018) Dis. Markers, 2018; Kienreich, K., Tomaschitz, A., Verheyen, N., Pieber, T., Gaksch, M., Gr�bler, M.R., Pilz, S., Vitamin D and cardiovascular disease (2013) Nutrients, 5 (8), pp. 3005-3021; Danik, J.S., Manson, J.E., Vitamin D and cardiovascular disease (2012) Curr. Treat. Options Cardiovasc. Med., 14 (4), pp. 414-424; Norman, P., Powell, J., Vitamin D and cardiovascular disease (2014) Circ. Res., 114 (2), pp. 379-393; Zhang, Y., Leung, D.Y., Richers, B.N., Liu, Y., Remigio, L.K., Riches, D.W., Goleva, E., Vitamin D inhibits monocyte/ macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1 (2012) J. Immunol., 188 (5), pp. 2127-2135; Canning, M.O., Grotenhuis, K., de Wit, H., Ruwhof, C., Drexhage, H.A., 1-alpha, 25-Dihydroxyvitamin D3 (1, 25 (OH)(2) D (3)) hampers the maturation of fully active immature dendritic cells from monocytes (2001) Europ. J. Endocrinol., 145 (3), pp. 351-357; Komar, A.A., Single nucleotide polymorphisms (2009) Methods Mol. Biol., p. 578; Gozdzik, A., Zhu, J., Wong, B.Y., Fu, L., Cole, D.E., Parra, E.J., Association of vitamin D binding protein (VDBP) polymorphisms and serum 25(OH)D concentrations in a sample of young Canadian adults of different ancestry (2011) J. Steroid Biochem. Mol. Biol., 127 (3-5), pp. 405-412; Ramos-Lopez, E., Br�ck, P., Jansen, T., Herwig, J., Badenhoop, K., CYP2R1 (Vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans (2007) Diabet./Metabol. Res. Rev., 23 (8), pp. 631-636; Zhang, Z., He, J.W., Fu, W.Z., Zhang, C.Q., Zhang, Z.L., An analysis of the association between the vitamin D pathway and serum 25-hydroxyvitamin D levels in a healthy Chinese population (2013) J. Bone Mineral Res, 28 (8), pp. 1784-1792; Zhang, Y., Wang, X., Liu, Y., Qu, H., Qu, S., Wang, W., Ren, L., The GC, CYP2R1 and DHCR7 genes are associated with vitamin D levels in northeastern Han Chinese children (2012) Swiss Med. Wkly, 142; Elkum, N., Alkayal, F., Noronha, F., Ali, M.M., Melhem, M., Al-Arouj, M., Bennakhi, A., Abubaker, J., Vitamin D insufficiency in Arabs and South Asians positively associates with polymorphisms in GC and CYP2R1 genes (2014) PLOS One, 9 (11); Bu, F.-X., Armas, L., Lappe, J., Zhou, Y., Gao, G., Wang, H.-W., Recker, R., Zhao, L.-J., Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects (2010) Human Genetics, 128 (5), pp. 549-556; Lu, L., Sheng, H., Li, H., Gan, W., Liu, C., Zhu, J., Loos, R.J., Lin, X., Associations between common variants in GC and DHCR7/NADSYN1 and vitamin D concentration in Chinese Hans (2012) Human Genetics, 131 (3), pp. 505-512; Ahn, J., Yu, K., Stolzenberg-Solomon, R., Simon, K.C., McCullough, M.L., Gallicchio, L., Jacobs, E.J., Jacobs, K.B., Genome-wide association study of circulating vitamin D levels (2010) Human Mol. Genet., 19 (13), pp. 2739-2745; Rees, J.R., Mott, L.A., Barry, E.L., Baron, J.A., Bostick, R.M., Figueiredo, J.C., Bresalier, R.S., Peacock, J.L., Lifestyle and other factors explain one-half of the variability in the serum 25-hydroxyvitamin D response to cholecalciferol supplementation in healthy adults (2016) J. Nutrit., 146 (11), pp. 2312-2324; Robien, K., Butler, L.M., Wang, R., Beckman, K.B., Walek, D., Koh, W.-P., Yuan, J.-M., Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore (2013) Brit. J. Nutrit., 109 (3), pp. 493-502; Sadat-Ali, M., Al-Turki, H.A., Azam, M.Q., Al-Elq, A.H., Genetic influence on circulating vitamin D among Saudi Arabians (2016) Saudi Med. J., 37 (9), p. 996; Hassanein, S.I., Abu El Maaty, M.A., Sleem, H.M., Gad, M.Z., Triangular relationship between single nucleotide polymorphisms in the CYP2R1 gene (Rs10741657 and rs12794714), 25-hydroxyvitamin d levels, and coronary artery disease incidence (2014) Biomarkers, 19 (6), pp. 488-492 | |
dcterms.source | Scopus |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- avatar_scholar_256.png
- Size:
- 6.31 KB
- Format:
- Portable Network Graphics
- Description: